Literature DB >> 19997781

Several dystrophin-glycoprotein complex members are present in crude surface membranes but they are sodium dodecyl sulphate invisible in KCl-washed microsomes from mdx mouse muscle.

Stéphanie Daval1, Chantal Rocher, Yan Cherel, Elisabeth Le Rumeur.   

Abstract

The dystrophin-glycoprotein complex (DGC) is a large trans-sarcolemmal complex that provides a linkage between the subsarcolemmal cytoskeleton and the extracellular matrix. In skeletal muscle, it consists of the dystroglycan, sarcoglycan and cytoplasmic complexes, with dystrophin forming the core protein. The DGC has been described as being absent or greatly reduced in dystrophin-deficient muscles, and this lack is considered to be involved in the dystrophic phenotype. Such a decrease in the DGC content was observed in dystrophin-deficient muscle from humans with muscular dystrophy and in mice with X-linked muscular dystrophy (mdx mice). These deficits were observed in total muscle homogenates and in partially membrane-purified muscle fractions, the so-called KCl-washed microsomes. Here, we report that most of the proteins of the DGC are actually present at normal levels in the mdx mouse muscle plasma membrane. The proteins are detected in dystrophic animal muscles when the immunoblot assay is performed with crude surface membrane fractions instead of the usually employed KCl-washed microsomes. We propose that these proteins form SDS-insoluble membrane complexes when dystrophin is absent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19997781      PMCID: PMC6276006          DOI: 10.2478/s11658-009-0039-8

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  53 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

3.  Evaluation of the application of sodium deoxycholate to proteomic analysis of rat hippocampal plasma membrane.

Authors:  Jian Zhou; Tieyang Zhou; Rui Cao; Zhen Liu; Jianying Shen; Ping Chen; Xianchun Wang; Songping Liang
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

4.  An ischemic beta-dystroglycan (betaDG) degradation product: correlation with irreversible injury in adult rabbit cardiomyocytes.

Authors:  Stephen C Armstrong; Carole A Latham; Charles E Ganote
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 5.  Dystrophin-associated proteins in muscular dystrophy.

Authors:  E Ozawa; M Yoshida; A Suzuki; Y Mizuno; Y Hagiwara; S Noguchi
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

6.  Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.

Authors:  D J Wells; K E Wells; E A Asante; G Turner; Y Sunada; K P Campbell; F S Walsh; G Dickson
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

7.  The muscle protein dysferlin accumulates in the Alzheimer brain.

Authors:  James E Galvin; Divya Palamand; Jeff Strider; Margherita Milone; Alan Pestronk
Journal:  Acta Neuropathol       Date:  2006-10-06       Impact factor: 17.088

8.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

9.  Differential association of syntrophin pairs with the dystrophin complex.

Authors:  M F Peters; M E Adams; S C Froehner
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

10.  Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice.

Authors:  K Ohlendieck; K P Campbell
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  2 in total

1.  A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.

Authors:  Kumaran Chandrasekharan; Jung Hae Yoon; Ying Xu; Sarah deVries; Marybeth Camboni; Paulus M L Janssen; Ajit Varki; Paul T Martin
Journal:  Sci Transl Med       Date:  2010-07-28       Impact factor: 17.956

2.  Mass spectrometric identification of dystrophin, the protein product of the Duchenne muscular dystrophy gene, in distinct muscle surface membranes.

Authors:  Sandra Murphy; Kay Ohlendieck
Journal:  Int J Mol Med       Date:  2017-07-27       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.